Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases.
Kikuchi J, Yamada S, Koyama D, Wada T, Nobuyoshi M, Izumi T, Akutsu M, Kano Y, Furukawa Y. Kikuchi J, et al. Among authors: yamada s. J Biol Chem. 2013 Aug 30;288(35):25593-25602. doi: 10.1074/jbc.M113.480574. Epub 2013 Jul 22. J Biol Chem. 2013. PMID: 23878197 Free PMC article. Clinical Trial.
Sleep Blood Pressure Self-Measured at Home as a Novel Determinant of Organ Damage: Japan Morning Surge Home Blood Pressure (J-HOP) Study.
Kario K, Hoshide S, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, Yano Y, Eguchi K, Matsui Y, Shimizu M, Ishikawa J, Ishikawa S; J-HOP study group. Kario K, et al. J Clin Hypertens (Greenwich). 2015 May;17(5):340-8. doi: 10.1111/jch.12500. Epub 2015 Feb 16. J Clin Hypertens (Greenwich). 2015. PMID: 25689113 Free PMC article. Clinical Trial.
[Guidelines for presymptomatic genetic testing for adult-onset hereditary neuromuscular diseases in Japan].
Shibata Y, Chang H, Nakamura K, Yamada S, Matsushima M, Saigoh K, Ishiura H, Sekijima Y, Maruyama H, Ikeuchi T, Hasegawa K, Aoki M, Katsuno M, Toda T, Yabe I; Committee on Medical Genetics, Japanese Society of Neurology. Shibata Y, et al. Among authors: yamada s. Rinsho Shinkeigaku. 2025 Jan 24. doi: 10.5692/clinicalneurol.cn-002049. Online ahead of print. Rinsho Shinkeigaku. 2025. PMID: 39864867 Japanese.
A 211At-labelled mGluR1 inhibitor induces cancer senescence to elicit long-lasting anti-tumor efficacy.
Xie L, Zhang L, Hu K, Hanyu M, Zhang Y, Fujinaga M, Minegishi K, Ohkubo T, Nagatsu K, Jiang C, Shimokawa T, Ashisuke K, Okonogi N, Yamada S, Wang F, Wang R, Zhang MR. Xie L, et al. Among authors: yamada s. Cell Rep Med. 2025 Jan 25:101945. doi: 10.1016/j.xcrm.2025.101945. Online ahead of print. Cell Rep Med. 2025. PMID: 39864439 No abstract available.
Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib.
Terashima T, Kido H, Takata N, Hayashi T, Seki A, Nakagawa H, Nio K, Toyama T, Iida N, Yamada S, Shimakami T, Takatori H, Arai K, Yamashita T, Mizukoshi E, Yamashita T. Terashima T, et al. Among authors: yamada s. Cancers (Basel). 2025 Jan 16;17(2):278. doi: 10.3390/cancers17020278. Cancers (Basel). 2025. PMID: 39858059 Free article.
8,555 results